OSURNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
ORASURE TECHNOLOGIES INC
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026
$3.68+0.07 (+1.94%)
Close on Oct 19, 2026
- Market cap
- $258.18M
- P/E (TTM)
- –
- Dividend yield
- –
Share price
+$0.66 (+21.85%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.Earnings
ORASURE TECHNOLOGIES INC saw revenue fall 18.9% to $112.41M over the twelve months to Jun 30, 2026. Free cash flow was -$48.07M.
Revenue
$112.41M
-18.9% vs. a year earlier
Operating income
-$54.02M
TTM Q2 2026
Free cash flow
-$48.07M
TTM Q2 2026
EPS, diluted
-$0.69
TTM Q2 2026
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Jun 30, 2026
Valuation
- Market cap
- $258.18M
- P/E ratio
- –
- Price to sales
- 2.30
- Price to book
- 0.81
- Dividend yield
- –
- Free cash flow yield
- -18.62%
Fundamentals
- Revenue
- $112.41M
- Net income
- -$49.13M
- EPS, diluted
- -$0.69
- Free cash flow
- -$48.07M
- Book value per share
- $4.53
- Diluted shares
- 70M
Fifteen years at a glance
Fiscal years 2011 to 2025 and trailing twelve months, USD
Revenue
$112.41M-18.9% YoY
Gross profit
$47.86M-14.7% YoY
Operating income
-$54.02M
Net income
-$49.13M
EPS, diluted
-$0.69
Free cash flow
-$48.07M
Reported periodTrailing twelve months